Vasoconstriction-Inhibiting Factor (Human) (0.1 mg vial)

Product overview
Catalog Number
PPH08-1042
Sequence
His-Ser-Gly-Phe-Glu-Asp-Glu-Leu-Ser-Glu-Val-Leu-Glu-Asn-Gln-Ser-Ser-Gln-Ala-Glu-Leu-Lys-Glu-Ala-Val-Glu-Glu-Pro-Ser-Ser-Lys-Asp-Val-Met-Glu
Target
Endogenous Modulator of Vasoconstrictive Effect of Angiotensin II
Description
Potent Endogenous Cofactor of Angiotensin II Acting on the AT2 Receptor. Vasoconstriction-Inhibiting Factor (Human) (VIF) The vasoregulatory effects of VIF are mediated by the AT2-receptor. VIF impairs Ang-II-induced phosphorylation of the p38MAPK-pathway but not of ERK1/2. The vasodilatory effects were confirmed in-vivo. The plasma concentration was significantly in-creased in renal and hear failure patients. Molecular Formula: C163H256N42O67S. Molecular Mass: 3908.1
Category
Product Properties
Quantity

1mg

Storage

Shipped at 4°C. Store at -20°C for one year.

Purity

> 95%

Source

Synthetic

Forma appearance

Lyophilized powder

Price

€100,00

  • For research use only
  • Not for use in diagnostic procedures

100,00 Tax excluded

Contact us to request price here
Register to buy peptides
Contact us